Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2018 / Mar / Sub-Zero Substitute
Quality assurance and quality control

Sub-Zero Substitute

MOFs could offer an alternative to freezing samples in low-income areas

By William Aryitey 03/16/2018 1 min read

Share

In certain regions of the world, pathologists have limited (or no) ability to conduct analytical tests – but it’s not always because of a lack of equipment or personnel; sometimes, it’s down to the inability to implement a cold chain to transport samples. No matter how good the pathologist or technique, if a sample is not properly preserved, it may not be usable for testing – or worse, it may give false results (see our cover feature to discover how worryingly widespread the problem is). A team of researchers from Washington University in St. Louis decided to tackle the gap in sample preservation, by enlisting the help of metal-organic frameworks (MOFs) (1).

“For the past few years, we have been working towards developing biodiagnostics for resource-limited settings,” says Srikanth Singamaneni, Associate Professor in the university’s School of Engineering. “As part of that effort, we have demonstrated the use of MOFs as protective encapsulants for preserving the functionality of antibodies conjugated to a biosensor surface. Following the successful completion of this work, we wondered if the technology could be used to protect protein biomarkers in the biospecimen, instead of antibodies on the sensor surface. And that led us to explore the use of MOFs for specimen preservation.” The team demonstrated their technique by encapsulating protein biomarkers in urine, blood, and plasma in a zeolitic imidazolate framework-8 (ZIF-8). When collected, samples need a MOF precursor added before being dried on filter paper. Recovering the protein for analysis simply involves dissociating ZIF-8 in a pH 6 buffer elution. Crucially, this final step doesn’t affect protein analysis, meaning that workflows are minimally impacted. The nanoporous MOF was able to preserve the proteins at both room temperature and 40°C in a comparable condition to samples frozen at -20°C. Singamaneni adds, “We have only explored proteins so far, but we would like to extend the technology to other biomarkers and test larger numbers of patient samples. We believe that the technique should be applicable to other biomarkers, such as nucleic acids and metabolites.” He also notes that the reagents used are inexpensive and commercially available, meaning that the technique should be possible in even the most resource-limited areas.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. C Wang et al., “Metal-organic framework encapsulation for biospecimen preservation”, Chem Mater, Chem Mater, 30, 1291–1300 (2018).

About the Author(s)

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

More Articles by William Aryitey

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

R-Tracker: The First of Its Kind
Quality assurance and quality control
R-Tracker: The First of Its Kind

December 29, 2021

1 min read

Milestone is committed to enhancing patient safety with a new disruptive technology

The Big Freeze
Quality assurance and quality control
The Big Freeze

February 7, 2022

1 min read

Cryobioprinting could maximize the shelf life of bioprinted 3D tissues

Biospecimen Access For Biotechs
Quality assurance and quality control
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Questions of Quality
Quality assurance and quality control
Questions of Quality

October 21, 2016

1 min read

The importance of quality is broadly accepted – witness the plethora of standards and guidelines – but do they lead to effective implementation?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.